本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Crescent Biopharma Inc

19.41
-0.0500-0.26%
成交量:26.44萬
成交額:515.33萬
市值:7.21億
市盈率:-2.62
高:20.35
開:19.81
低:19.11
收:19.46
52周最高:27.41
52周最低:8.72
股本:3,714.39萬
流通股本:1,595.35萬
量比:0.60
換手率:1.66%
股息:- -
股息率:- -
每股收益(TTM):-7.4105
每股收益(LYR):-12.8150
淨資產收益率:-160.75%
總資產收益率:-69.15%
市淨率:9.94
市盈率(LYR):-1.51

資料載入中...

2022/03/31

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/16

重要事件披露

8-K - Current report
2022/03/16

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/03/07

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/03/04

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/28

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/02/23

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/02/18

重要事件披露

8-K - Current report
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/27

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/01/25

重要事件披露

8-K - Current report
2022/01/12

重要事件披露

8-K - Current report
2022/01/05

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/10/21

持股變動聲明

3 - Initial statement of beneficial ownership of securities
2021/10/05

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/10/05

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/10/05

持股變動聲明

4 - Statement of changes in beneficial ownership of securities